Basic Information
Relistor Solution For Injection 12mg/0.6mL
INJECTION, SOLUTION
Regulatory Information
SIN13783P
April 7, 2010
Prescription Only
Therapeutic
SUBCUTANEOUS
August 10, 2023
June 4, 2025
XA06AH01
Company Information
Active Ingredients
Methylnaltrexone Bromide
Strength: 12mg/0.6mL
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to the active substance or to any of the excipients. Use of methylnaltrexone bromide in patients with known or suspected mechanical gastrointestinal obstruction or acute surgical abdomen is contraindicated.
Indication Information
**4.1 Therapeutic indications** Treatment of opioid-induced constipation in advanced illness patients who are receiving palliative care when response to usual laxative therapy has not been sufficient.